Effects of bezafibrate on the serum lipoprotein lipid and apolipoprotein composition, lipoprotein triglyceride removal capacity and the fatty acid composition of the plasma lipid esters
- 1 October 1980
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 37 (2), 257-269
- https://doi.org/10.1016/0021-9150(80)90011-8
Abstract
No abstract availableKeywords
Funding Information
- Medicinska Forskningsrådet (19P-5640, 19X-6546-02)
This publication has 32 references indexed in Scilit:
- Changes in the fatty acid composition of the plasma lipid esters during lipid-lowering treatment with diet, clofibrate and niceritrol Reduction of the proportion of linoleate by clofibrate but not by niceritrolAtherosclerosis, 1980
- Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic diseaseAtherosclerosis, 1979
- One-year study of the effect of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemiaAtherosclerosis, 1978
- Dose-response study of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemiaAtherosclerosis, 1978
- Increase of the lipoprotein‐lipase activity in human skeletal muscle during clof ibrate administrationEuropean Journal of Clinical Investigation, 1978
- Comparison of assay methods for selective measurement of plasma lipaseAtherosclerosis, 1977
- Quantitative and qualitative serum lipoprotein analysisAtherosclerosis, 1975
- A Methodological Study of an Intravenous Fat Tolerance Test with IntralipidREmulsionScandinavian Journal of Clinical and Laboratory Investigation, 1972
- Radioimmunosorbent assay for proteins. Chemical couplings of antibodies to insoluble dextranImmunochemistry, 1967
- Sur un dosage rapide du cholesterol lié aux α-et aux β-lipoprotéines du sérumClinica Chimica Acta; International Journal of Clinical Chemistry, 1960